Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $3000.0.

  • Precision Biosciences' Gains from Investment Securities fell 9927.06% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$830000.0, marking a year-over-year decrease of 30181.44%. This contributed to the annual value of $376551.0 for FY2024, which is 769.0% up from last year.
  • Per Precision Biosciences' latest filing, its Gains from Investment Securities stood at $3000.0 for Q3 2025, which was down 9927.06% from -$25000.0 recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Gains from Investment Securities registered a high of $13.9 million during Q2 2022, and its lowest value of -$626000.0 during Q4 2023.
  • Over the past 5 years, Precision Biosciences' median Gains from Investment Securities value was $393432.5 (recorded in 2024), while the average stood at $4.5 million.
  • As far as peak fluctuations go, Precision Biosciences' Gains from Investment Securities tumbled by 18258.58% in 2023, and later surged by 488661.43% in 2024.
  • Over the past 5 years, Precision Biosciences' Gains from Investment Securities (Quarter) stood at $9.6 million in 2021, then tumbled by 92.12% to $758000.0 in 2022, then crashed by 182.59% to -$626000.0 in 2023, then surged by 70.93% to -$182000.0 in 2024, then soared by 101.65% to $3000.0 in 2025.
  • Its Gains from Investment Securities stands at $3000.0 for Q3 2025, versus -$25000.0 for Q2 2025 and $375596.0 for Q1 2025.